Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: After-Hours Movers » 18:50
07/22/21
07/22
18:50
07/22/21
18:50
SNAP

Snap

$63.03 /

-0.345 (-0.54%)

, SKX

Skechers

$51.22 /

+0.93 (+1.85%)

, RHI

Robert Half

$86.55 /

-0.9 (-1.03%)

, TWTR

Twitter

$69.55 /

+0.03 (+0.04%)

, WRB

W. R. Berkley

$75.22 /

-1.27 (-1.66%)

, CE

Celanese

$148.89 /

-2.73 (-1.80%)

, TACO

Del Taco

$9.54 /

+0.18 (+1.92%)

, OCUL

Ocular Therapeutix

$12.12 /

-0.55 (-4.34%)

, SAM

Boston Beer

$954.75 /

+27.1 (+2.92%)

, BOOM

DMC Global

$47.06 /

-3.16 (-6.29%)

, VRSN

VeriSign

$233.40 /

+3.61 (+1.57%)

, COF

Capital One

$161.32 /

-1.885 (-1.16%)

, INTC

Intel

$55.97 /

-0.26 (-0.46%)

, ADVM

Adverum Biotechnologies

$3.07 /

-0.08 (-2.54%)

Check out this evening's…

ShowHide Related Items >><<
WRB W. R. Berkley
$75.22 /

-1.27 (-1.66%)

VRSN VeriSign
$233.40 /

+3.61 (+1.57%)

TWTR Twitter
$69.55 /

+0.03 (+0.04%)

TACO Del Taco
$9.54 /

+0.18 (+1.92%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

SKX Skechers
$51.22 /

+0.93 (+1.85%)

SAM Boston Beer
$954.75 /

+27.1 (+2.92%)

RHI Robert Half
$86.55 /

-0.9 (-1.03%)

OCUL Ocular Therapeutix
$12.12 /

-0.55 (-4.34%)

INTC Intel
$55.97 /

-0.26 (-0.46%)

COF Capital One
$161.32 /

-1.885 (-1.16%)

CE Celanese
$148.89 /

-2.73 (-1.80%)

BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

ADVM Adverum Biotechnologies
$3.07 /

-0.08 (-2.54%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

07/20/21 Jefferies
Twitter price target raised to $70 from $62 at Jefferies
07/20/21 Credit Suisse
Snap price target raised to $90 from $80 at Credit Suisse
07/15/21 JPMorgan
JPMorgan prefers Twitter over Snap into earnings
06/02/21 Cowen
Poshmark pent up demand for apparel should bode well, says Cowen
SKX Skechers
$51.22 /

+0.93 (+1.85%)

07/21/21 Cowen
Skechers price target raised to $55 from $50 at Cowen
07/20/21 Monness Crespi
Skechers upgraded to Buy from Neutral at Monness Crespi
07/15/21 Deutsche Bank
Skechers price target raised to $62 from $59 at Deutsche Bank
04/23/21 Williams Capital
Skechers guidance doesn't warrant current valuation, says Williams Trading
RHI Robert Half
$86.55 /

-0.9 (-1.03%)

04/26/21 Barclays
Robert Half price target raised to $95 from $85 at Barclays
04/22/21 Truist
Robert Half price target raised to $85 from $67 at Truist
04/22/21 Credit Suisse
Robert Half price target raised to $70 from $60 at Credit Suisse
04/22/21 Baird
Robert Half price target raised to $111 from $104 at Baird
TWTR Twitter
$69.55 /

+0.03 (+0.04%)

06/09/21 Vertical Group
Twitter upgraded to Very Positive from Mixed/Positive at Vertical Group
06/04/21 Mizuho
Twitter subscription service could drive 'modest' sales upside, says Mizuho
WRB W. R. Berkley
$75.22 /

-1.27 (-1.66%)

04/21/21 Deutsche Bank
W. R. Berkley price target raised to $80 from $70 at Deutsche Bank
04/07/21 Wells Fargo
W. R. Berkley initiated with an Overweight at Wells Fargo
02/24/21 UBS
W. R. Berkley upgraded to Buy from Neutral at UBS
02/24/21 UBS
W. R. Berkley upgraded to Buy from Neutral at UBS
CE Celanese
$148.89 /

-2.73 (-1.80%)

07/01/21
Fly Intel: Top five analyst upgrades
07/01/21 Deutsche Bank
Deutsche Bank upgrades Celanese to Buy on capital deployment
07/01/21 Deutsche Bank
Celanese upgraded to Buy from Hold at Deutsche Bank
06/21/21 Baird
Celanese remains a top pick at Baird
TACO Del Taco
$9.54 /

+0.18 (+1.92%)

03/09/21 CL King
Del Taco outpaced restaurant-level operating margin assumptions, says CL King
09/17/20 CL King
Del Taco price target raised to $13 from $11 at CL King
09/16/20 Jefferies
Del Taco price target raised to $10 from $8.50 at Jefferies
09/14/20 Piper Sandler
Del Taco price target raised to $8 from $7 at Piper Sandler
OCUL Ocular Therapeutix
$12.12 /

-0.55 (-4.34%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
SAM Boston Beer
$954.75 /

+27.1 (+2.92%)

07/21/21 RBC Capital
Boston Beer price target lowered to $1,466 from $1,538 at RBC Capital
07/16/21 Evercore ISI
Boston Beer price target lowered to $1,250 from $1,600 at Evercore ISI
07/12/21 Morgan Stanley
Boston Beer price target lowered to $1,450 from $1,530 at Morgan Stanley
07/09/21 Deutsche Bank
Boston Beer price target lowered to $1,074 from $1,280 at Deutsche Bank
BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

04/01/21 Roth Capital
Roth Capital sees DMC as under the radar beneficiary of Infrastructure Plan
02/19/21 Stifel
DMC Global price target raised to $67 from $53 at Stifel
02/17/21 Roth Capital
DMC Global price target raised to $50 from $34 at Roth Capital
09/11/20 Sidoti
DMC Global re-initiated with a Neutral at Sidoti
VRSN VeriSign
$233.40 /

+3.61 (+1.57%)

04/23/21 Citi
VeriSign price target raised to $245 from $235 at Citi
12/09/20
Fly Intel: Top five analyst upgrades
12/09/20 JPMorgan
VeriSign upgraded to Overweight from Neutral at JPMorgan
COF Capital One
$161.32 /

-1.885 (-1.16%)

07/19/21 Odeon Capital
Capital One upgraded to Hold from Sell at Odeon Capital
07/12/21 Wells Fargo
Capital One price target raised to $180 from $155 at Wells Fargo
07/02/21 Credit Suisse
Capital One price target raised to $182 from $175 at Credit Suisse
07/02/21 Piper Sandler
Capital One price target raised to $170 from $169 at Piper Sandler
INTC Intel
$55.97 /

-0.26 (-0.46%)

07/21/21 Citi
Citi expects 'negative catalysts' from Intel's Q2 report
07/20/21 Susquehanna
Intel setup achievable given lowered bar, says Susquehanna
07/16/21 KeyBanc
Intel acquisition of GlobalFoundries would be 'positive,' says KeyBanc
07/15/21 Citi
AMD upgraded to Neutral from Sell at Citi
ADVM Adverum Biotechnologies
$3.07 /

-0.08 (-2.54%)

07/09/21 Chardan
Adverum Biotechnologies coverage transferred at Chardan
05/03/21 SVB Leerink
Adverum Biotechnologies downgraded to Market Perform at SVB Leerink
05/03/21 SVB Leerink
Adverum Biotechnologies downgraded to Market Perform from Outperform at SVB Leerink
04/29/21 Chardan
Chardan downgrades Adverum after serious adverse reaction disclosure
WRB W. R. Berkley
$75.22 /

-1.27 (-1.66%)

VRSN VeriSign
$233.40 /

+3.61 (+1.57%)

TWTR Twitter
$69.55 /

+0.03 (+0.04%)

TACO Del Taco
$9.54 /

+0.18 (+1.92%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

SKX Skechers
$51.22 /

+0.93 (+1.85%)

SAM Boston Beer
$954.75 /

+27.1 (+2.92%)

RHI Robert Half
$86.55 /

-0.9 (-1.03%)

OCUL Ocular Therapeutix
$12.12 /

-0.55 (-4.34%)

INTC Intel
$55.97 /

-0.26 (-0.46%)

COF Capital One
$161.32 /

-1.885 (-1.16%)

CE Celanese
$148.89 /

-2.73 (-1.80%)

BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

ADVM Adverum Biotechnologies
$3.07 /

-0.08 (-2.54%)

  • 05
    May
  • 16
    Dec
  • 14
    Oct
  • 13
    Aug
TWTR Twitter
$69.55 /

+0.03 (+0.04%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

INTC Intel
$55.97 /

-0.26 (-0.46%)

CE Celanese
$148.89 /

-2.73 (-1.80%)

VRSN VeriSign
$233.40 /

+3.61 (+1.57%)

TWTR Twitter
$69.55 /

+0.03 (+0.04%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

SKX Skechers
$51.22 /

+0.93 (+1.85%)

SAM Boston Beer
$954.75 /

+27.1 (+2.92%)

RHI Robert Half
$86.55 /

-0.9 (-1.03%)

OCUL Ocular Therapeutix
$12.12 /

-0.55 (-4.34%)

INTC Intel
$55.97 /

-0.26 (-0.46%)

COF Capital One
$161.32 /

-1.885 (-1.16%)

CE Celanese
$148.89 /

-2.73 (-1.80%)

BOOM DMC Global
$47.06 /

-3.16 (-6.29%)

ADVM Adverum Biotechnologies
$3.07 /

-0.08 (-2.54%)

TWTR Twitter
$69.55 /

+0.03 (+0.04%)

TACO Del Taco
$9.54 /

+0.18 (+1.92%)

SNAP Snap
$63.03 /

-0.345 (-0.54%)

SKX Skechers
$51.22 /

+0.93 (+1.85%)

RHI Robert Half
$86.55 /

-0.9 (-1.03%)

INTC Intel
$55.97 /

-0.26 (-0.46%)

COF Capital One
$161.32 /

-1.885 (-1.16%)

CE Celanese
$148.89 /

-2.73 (-1.80%)

Hot Stocks
Ocular Therapeutix reports preliminary Q2 product revenue of $11.7M » 16:02
07/22/21
07/22
16:02
07/22/21
16:02
OCUL

Ocular Therapeutix

$12.15 /

-0.52 (-4.10%)

The Company is reporting…

The Company is reporting preliminary second quarter 2021 total net product revenue of approximately $11.7 million, representing a greater than 600% year-over-year increase versus the second quarter 2020 and an approximately 60% sequential increase over the first quarter of 2021. Net product revenue of DEXTENZA 0.4mg for the quarter ended June 30, 2021 is estimated to be $11.1 million, and net product revenue of ReSure(R) Sealant for the quarter ended June 30, 2021 is estimated to be $0.6 million. "We are pleased by DEXTENZA's performance in the quarter and believe that continued physician interest and more normalized cataract procedure volumes bode well for strong growth through the remainder of the year," said Antony Mattessich, President and CEO. "What gives us the greatest satisfaction however is knowing that more and more patients are enjoying a better experience following their ophthalmic surgeries."

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$12.15 /

-0.52 (-4.10%)

OCUL Ocular Therapeutix
$12.15 /

-0.52 (-4.10%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
OCUL Ocular Therapeutix
$12.15 /

-0.52 (-4.10%)

  • 16
    Dec
  • 14
    Oct
OCUL Ocular Therapeutix
$12.15 /

-0.52 (-4.10%)

Over a month ago
Hot Stocks
Ocular Therapeutix, Mosaic Biosciences team on macular degeneration » 08:06
06/29/21
06/29
08:06
06/29/21
08:06
OCUL

Ocular Therapeutix

$14.04 /

-0.065 (-0.46%)

Ocular Therapeutix…

Ocular Therapeutix entered into a discovery collaboration with Mosaic Biosciences to identify new targets and therapeutic agents aimed at the treatment of Dry Age-related Macular Degeneration, dAMD. Under terms of the agreement, the collaboration between Ocular Therapeutix and Mosaic focuses on the discovery and development of novel complement inhibitors with extended duration of activity. The complement pathway represents a key component of innate immunity and maintains immune homeostasis throughout the body, including ocular tissues. Within the retina, the complement pathway has been associated with the development of age-related macular degeneration. The goal of complement inhibition is to block the pathway that can initiate and drive these diseases. "This agreement with Mosaic Biosciences marks an important step forward for our company and how we approach the discovery and development of ophthalmic products," said Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix. "Historically, our products have been developed by combining a known active pharmaceutical ingredient with our proprietary hydrogel technology to create innovate treatments for diseases of the eye. However, certain diseases are very challenging to treat with existing agents. Working with Mosaic, we hope to incorporate the discovery of new chemical entities into our current drug development approach and to identify novel, sustained release products to expand our innovative ophthalmic portfolio."

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$14.04 /

-0.065 (-0.46%)

OCUL Ocular Therapeutix
$14.04 /

-0.065 (-0.46%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
OCUL Ocular Therapeutix
$14.04 /

-0.065 (-0.46%)

  • 16
    Dec
  • 14
    Oct
OCUL Ocular Therapeutix
$14.04 /

-0.065 (-0.46%)

Conference/Events
Ocular Therapeutix management to meet virtually with JMP Securities » 04:55
05/19/21
05/19
04:55
05/19/21
04:55
OCUL

Ocular Therapeutix

$14.02 /

-0.06 (-0.43%)

Virtual Meeting to be…

Virtual Meeting to be held on May 19 hosted by JMP Securities.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$14.02 /

-0.06 (-0.43%)

OCUL Ocular Therapeutix
$14.02 /

-0.06 (-0.43%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
OCUL Ocular Therapeutix
$14.02 /

-0.06 (-0.43%)

  • 16
    Dec
  • 14
    Oct
  • 20
    May
OCUL Ocular Therapeutix
$14.02 /

-0.06 (-0.43%)

Conference/Events
Ocular Therapeutix management to meet virtually with JMP Securities » 14:46
05/17/21
05/17
14:46
05/17/21
14:46
OCUL

Ocular Therapeutix

$13.97 /

-0.8 (-5.42%)

Virtual Meeting to be…

Virtual Meeting to be held on May 19 hosted by JMP Securities.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$13.97 /

-0.8 (-5.42%)

OCUL Ocular Therapeutix
$13.97 /

-0.8 (-5.42%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
OCUL Ocular Therapeutix
$13.97 /

-0.8 (-5.42%)

  • 16
    Dec
  • 14
    Oct
  • 20
    May
OCUL Ocular Therapeutix
$13.97 /

-0.8 (-5.42%)

Earnings
Ocular Therapeutix reports Q1 EPS (24c), consensus (21c) » 16:06
05/05/21
05/05
16:06
05/05/21
16:06
OCUL

Ocular Therapeutix

$16.56 /

-0.13 (-0.78%)

Reports Q1 revenue…

Reports Q1 revenue $7.34M, consensus $7.64M. As of March 31, 2021, the Company had $209.4 million in cash and cash equivalents versus $228.1 million at December 31, 2020. Based on current plans and related estimates of anticipated cash inflows from DEXTENZA and ReSure product sales and cash outflows from operating expenses, the Company believes that existing cash and cash equivalents, as of March 31, 2021, will enable the Company to fund planned operating expenses, debt service obligations and capital expenditure requirements through 2023. This cash guidance is subject to a number of assumptions including those related to the severity and duration of the COVID-19 pandemic, the revenues and expenses associated with the commercialization of DEXTENZA, and the pace of research and clinical development programs, and other aspects of the business.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$16.56 /

-0.13 (-0.78%)

OCUL Ocular Therapeutix
$16.56 /

-0.13 (-0.78%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
OCUL Ocular Therapeutix
$16.56 /

-0.13 (-0.78%)

  • 16
    Dec
  • 14
    Oct
  • 20
    May
OCUL Ocular Therapeutix
$16.56 /

-0.13 (-0.78%)

Over a quarter ago
Hot Stocks
Ocular fulfills post-marketing approval requirements for ReSure Sealant » 08:11
05/03/21
05/03
08:11
05/03/21
08:11
OCUL

Ocular Therapeutix

$18.38 /

-0.8 (-4.17%)

Ocular Therapeutix has…

Ocular Therapeutix has received notification from the U.S. Food and Drug Administration confirming it has fulfilled all post-approval study requirements for ReSure Sealant, with a requirement to update the ReSure label reflecting the study results. As a condition for ReSure's pre-market approval application (PMA) in 2014, the FDA required two post-approval studies to be completed. The first, referred to as the Clinical Post-Approval Study, was completed in 2016. This notification marks the completion of the second, the Device Exposure Registry Study, a retrospective analysis comparing endophthalmitis rates from sites that purchased ReSure Sealant versus sites that did not. "We are happy to have completed the FDA's post-approval requirements for our ReSure Sealant product" said Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutics. "ReSure is well-regarded by anterior segment surgeons and this study only adds to the body of knowledge supporting its use." This retrospective study evaluated endophthalmitis rates at sites with access to ReSure compared with the rate at sites without access to ReSure using the American Academy of Ophthalmology's IRIS Registry ntelligent Research in Sight database. In total, 6.7 million eyes that underwent cataract surgery with insertion of an intraocular len016 and December 2019 were evaluated in the study. The endophthalmitis rates for sites with access to ReSure was 0.609 per 1,000 surgeries, compared with 0.660 per 1,000 surgeries for sites without access to ReSure . Overall, the results of the study demonstrated there was no clinically or statistically significant difference in the incidence of endophthalmitis within 30 days of any cataract surgery between cohorts with and without access to ReSure Sealant. Ocular plans to submit a PMA supplement to modify the existing ReSure label to reflect the findings from the recently completed study

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$18.38 /

-0.8 (-4.17%)

OCUL Ocular Therapeutix
$18.38 /

-0.8 (-4.17%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
OCUL Ocular Therapeutix
$18.38 /

-0.8 (-4.17%)

  • 16
    Dec
  • 14
    Oct
  • 20
    May
OCUL Ocular Therapeutix
$18.38 /

-0.8 (-4.17%)

On The Fly
Fly Intel: Pre-market Movers » 08:53
03/12/21
03/12
08:53
03/12/21
08:53
LB

L Brands

$55.83 /

+1.1 (+2.01%)

, CFRX

ContraFect

$6.32 /

+1.25 (+24.65%)

, NVAX

Novavax

$187.62 /

+15.04 (+8.71%)

, WISA

Summit Wireless

$3.50 /

+0.31 (+9.72%)

, ITRM

Iterum Therapeutics

$1.60 /

+0.23 (+16.79%)

, DSSI

Diamond S Shipping

$9.39 /

+0.1 (+1.08%)

, OCUL

Ocular Therapeutix

$20.26 /

+0.58 (+2.95%)

, POSH

Poshmark

$59.28 /

+7.97 (+15.53%)

, RIDE

Lordstown Motors

$17.70 /

+0.705 (+4.15%)

, MRKR

Marker Therapeutics

$2.52 /

+0.01 (+0.40%)

, POWW

AMMO

$6.75 /

+0.45 (+7.14%)

, DS

Drive Shack

$2.66 /

+0.1 (+3.91%)

Check out this morning's…

ShowHide Related Items >><<
RIDE Lordstown Motors
$17.70 /

+0.705 (+4.15%)

POWW AMMO
$6.75 /

+0.45 (+7.14%)

POSH Poshmark
$59.28 /

+7.97 (+15.53%)

OCUL Ocular Therapeutix
$20.26 /

+0.58 (+2.95%)

NVAX Novavax
$187.62 /

+15.04 (+8.71%)

MRKR Marker Therapeutics
$2.52 /

+0.01 (+0.40%)

LB L Brands
$55.83 /

+1.1 (+2.01%)

ITRM Iterum Therapeutics
$1.60 /

+0.23 (+16.79%)

DSSI Diamond S Shipping
$9.39 /

+0.1 (+1.08%)

DS Drive Shack
$2.66 /

+0.1 (+3.91%)

CFRX ContraFect
$6.32 /

+1.25 (+24.65%)

LB L Brands
$55.83 /

+1.1 (+2.01%)

02/26/21
Fly Intel: Top five analyst upgrades
02/26/21 Citi
L Brands upgraded to Neutral from Sell at Citi
02/26/21 Morgan Stanley
Morgan Stanley upgrades L Brands on improved post-COVID profitability
02/26/21 KeyBanc
L Brands price target raised to $64 from $59 at KeyBanc
CFRX ContraFect
$6.32 /

+1.25 (+24.65%)

06/09/20
Fly Intel: Top five analyst initiations
06/09/20 Mizuho
ContraFect initiated with a Buy at Mizuho
06/08/20 Cantor Fitzgerald
ContraFect initiated with an Overweight at Cantor Fitzgerald
NVAX Novavax
$187.62 /

+15.04 (+8.71%)

03/12/21 H.C. Wainwright
Novavax price target raised to $317 from $207 at H.C. Wainwright
02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/22/21 Cantor Fitzgerald
Cantor says PREVENT-19 gives Novavax potential for differentiated analyses
02/22/21 B. Riley
B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up
WISA Summit Wireless
$3.50 /

+0.31 (+9.72%)

01/13/21 H.C. Wainwright
Summit Wireless price target raised to $5.50 from $3.50 at H.C. Wainwright
12/14/20 H.C. Wainwright
Summit Wireless initiated with a Buy at H.C. Wainwright
10/01/20
Fly Intel: Top five analyst initiations
10/01/20 Maxim
Summit Wireless initiated with a Buy at Maxim
ITRM Iterum Therapeutics
$1.60 /

+0.23 (+16.79%)

12/24/20 H.C. Wainwright
Iterum CSO resignation 'somewhat troubling,' says H.C. Wainwright
06/16/20 H.C. Wainwright
Iterum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
06/02/20 RBC Capital
Iterum Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
DSSI Diamond S Shipping
$9.39 /

+0.1 (+1.08%)

01/29/21 Jefferies
Diamond S Shipping price target lowered to $10 from $11 at Jefferies
07/15/20 B. Riley
Diamond S Shipping price target lowered to $21 from $25 at B. Riley FBR
03/30/20 Fearnley
Diamond S Shipping downgraded to Hold from Buy at Fearnley
OCUL Ocular Therapeutix
$20.26 /

+0.58 (+2.95%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
POSH Poshmark
$59.28 /

+7.97 (+15.53%)

03/12/21 Raymond James
Poshmark price target lowered to $68 from $83 at Raymond James
03/12/21 Cowen
Poshmark price target lowered to $70 from $88 at Cowen
02/22/21 Evercore ISI
Evercore upgrades Foot Locker to Outperform on 'cemented' sneaker position
02/08/21
Fly Intel: Top five analyst initiations
RIDE Lordstown Motors
$17.70 /

+0.705 (+4.15%)

02/24/21 Oppenheimer
Opco downgrades Workhorse after Postal Service snub despite backlog
02/11/21 Morgan Stanley
Lordstown Motors initiated with an Underweight at Morgan Stanley
01/29/21 Wolfe Research
Wolfe upgrades Lordstown Motors to Peer Perform, says 'narrative has changed'
01/29/21 Wolfe Research
Lordstown Motors upgraded to Peer Perform from Underperform at Wolfe Research
MRKR Marker Therapeutics
$2.52 /

+0.01 (+0.40%)

01/05/21 Oppenheimer
Marker hits 'important milestone' with end of clinical hold, says Oppenheimer
05/12/20
Fly Intel: Top five analyst downgrades
05/12/20 Piper Sandler
Marker Therapeutics downgraded to Neutral from Overweight at Piper Sandler
POWW AMMO
$6.75 /

+0.45 (+7.14%)

DS Drive Shack
$2.66 /

+0.1 (+3.91%)

12/17/20 B. Riley
Drive Shack price target raised to $5.50 from $4 at B. Riley Securities
12/09/20 B. Riley
Drive Shack shares can nearly double from current levels, says at B. Riley
06/01/20
Fly Intel: Top five analyst initiations
06/01/20 B. Riley
B. Riley FBR starts Drive Shack at Buy on 'eatertainment' concept plans
WISA Summit Wireless
$3.50 /

+0.31 (+9.72%)

RIDE Lordstown Motors
$17.70 /

+0.705 (+4.15%)

POWW AMMO
$6.75 /

+0.45 (+7.14%)

POSH Poshmark
$59.28 /

+7.97 (+15.53%)

OCUL Ocular Therapeutix
$20.26 /

+0.58 (+2.95%)

NVAX Novavax
$187.62 /

+15.04 (+8.71%)

MRKR Marker Therapeutics
$2.52 /

+0.01 (+0.40%)

LB L Brands
$55.83 /

+1.1 (+2.01%)

ITRM Iterum Therapeutics
$1.60 /

+0.23 (+16.79%)

DSSI Diamond S Shipping
$9.39 /

+0.1 (+1.08%)

DS Drive Shack
$2.66 /

+0.1 (+3.91%)

CFRX ContraFect
$6.32 /

+1.25 (+24.65%)

  • 12
    Mar
  • 12
    Mar
  • 29
    Jan
  • 14
    Jan
  • 16
    Dec
  • 01
    Dec
  • 14
    Oct
  • 22
    May
  • 20
    May
RIDE Lordstown Motors
$17.70 /

+0.705 (+4.15%)

NVAX Novavax
$187.62 /

+15.04 (+8.71%)

LB L Brands
$55.83 /

+1.1 (+2.01%)

WISA Summit Wireless
$3.50 /

+0.31 (+9.72%)

RIDE Lordstown Motors
$17.70 /

+0.705 (+4.15%)

POSH Poshmark
$59.28 /

+7.97 (+15.53%)

OCUL Ocular Therapeutix
$20.26 /

+0.58 (+2.95%)

NVAX Novavax
$187.62 /

+15.04 (+8.71%)

LB L Brands
$55.83 /

+1.1 (+2.01%)

RIDE Lordstown Motors
$17.70 /

+0.705 (+4.15%)

POWW AMMO
$6.75 /

+0.45 (+7.14%)

NVAX Novavax
$187.62 /

+15.04 (+8.71%)

LB L Brands
$55.83 /

+1.1 (+2.01%)

Earnings
Ocular Therapeutix reports Q4 EPS ($1.21), consensus (17c) » 16:03
03/11/21
03/11
16:03
03/11/21
16:03
OCUL

Ocular Therapeutix

$20.13 /

+0.45 (+2.29%)

Reports Q4 revenue…

Reports Q4 revenue $7.35M, consensus $9.76M. As of March 2, 2021, the Company had 76.1 million shares outstanding. As of the full year ended December 31, 2020, the Company had $228.1 million in cash and cash equivalents versus $54.4 million at December 31, 2019. Based on our current plans and related estimates of anticipated cash inflows from DEXTENZA and ReSure product sales and cash outflows from operating expenses, the Company believes that existing cash and cash equivalents, as of December 31, 2020, will enable the Company to fund planned operating expenses, debt service obligations and capital expenditure requirements through 2023. This cash guidance is subject to a number of assumptions including those related to the severity and duration of the COVID-19 pandemic, the revenues and expenses associated with the commercialization of DEXTENZA, and the pace of research and clinical development programs, and other aspects of the business.

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$20.13 /

+0.45 (+2.29%)

OCUL Ocular Therapeutix
$20.13 /

+0.45 (+2.29%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
OCUL Ocular Therapeutix
$20.13 /

+0.45 (+2.29%)

  • 16
    Dec
  • 14
    Oct
  • 20
    May
OCUL Ocular Therapeutix
$20.13 /

+0.45 (+2.29%)

On The Fly
Fly Intel: After-Hours Movers » 19:09
03/04/21
03/04
19:09
03/04/21
19:09
PLYA

Playa Hotels & Resorts

$6.90 /

-0.105 (-1.50%)

, MANU

Manchester United

$18.72 /

-0.84 (-4.29%)

, GPS

Gap

$25.43 /

-0.31 (-1.20%)

, NX

Quanex

$24.56 /

-0.26 (-1.05%)

, COO

Cooper Companies

$371.84 /

-9.125 (-2.40%)

, ATEC

Alphatec

$15.86 /

-0.69 (-4.17%)

, SWBI

Smith & Wesson Brands

$15.79 /

-0.54 (-3.31%)

, IMAX

Imax

$20.78 /

-0.98 (-4.50%)

, JAMF

Jamf Holding

$36.45 /

-1.33 (-3.52%)

, WTRH

Waitr Holdings

$2.99 /

-0.19 (-5.97%)

, OCUL

Ocular Therapeutix

$17.29 /

-0.31 (-1.76%)

, WDC

Western Digital

$63.48 /

-6.3 (-9.03%)

, EVFM

Evofem

$3.27 /

-0.325 (-9.05%)

, MDLA

Medallia

$37.82 /

-2.01 (-5.05%)

, DMTK

DermTech

$52.64 /

-11.36 (-17.75%)

, OPEN

Opendoor Technologies

$24.40 /

-4.46 (-15.45%)

, SDC

SmileDirectClub

$10.63 /

-0.28 (-2.57%)

, GWRE

Guidewire

$106.80 /

-2.79 (-2.55%)

, COST

Costco

$319.35 /

-4.53 (-1.40%)

, AVGO

Broadcom

$443.23 /

-19.235 (-4.16%)

, WORK

Slack Technologies

$39.97 /

-0.26 (-0.65%)

Check out this evening's…

ShowHide Related Items >><<
WTRH Waitr Holdings
$2.99 /

-0.19 (-5.97%)

WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

OCUL Ocular Therapeutix
$17.29 /

-0.31 (-1.76%)

NX Quanex
$24.56 /

-0.26 (-1.05%)

MDLA Medallia
$37.82 /

-2.01 (-5.05%)

MANU Manchester United
$18.72 /

-0.84 (-4.29%)

JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

GWRE Guidewire
$106.80 /

-2.79 (-2.55%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

EVFM Evofem
$3.27 /

-0.325 (-9.05%)

DMTK DermTech
$52.64 /

-11.36 (-17.75%)

COST Costco
$319.35 /

-4.53 (-1.40%)

COO Cooper Companies
$371.84 /

-9.125 (-2.40%)

AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

01/11/21 Macquarie
Playa Hotels & Resorts price target raised to $8 from $7 at Macquarie
12/15/20 Citi
Playa Hotels & Resorts upgraded to Neutral from Sell at Citi
07/02/20 Citi
Playa Hotels & Resorts price target raised to $3 from $1 at Citi
04/29/20 Truist
Playa Hotels & Resorts downgraded to Hold from Buy at SunTrust
MANU Manchester United
$18.72 /

-0.84 (-4.29%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

02/16/21 Jefferies
Gap assumed with a Hold at Jefferies
01/21/21 Deutsche Bank
Gap price target raised to $26 from $25 at Deutsche Bank
01/15/21 B. Riley
Gap price target lowered to $22 from $31 at B. Riley Securities
11/25/20
Fly Intel: Top five analyst downgrades
NX Quanex
$24.56 /

-0.26 (-1.05%)

09/04/20 CJS Securities
Quanex upgraded to Outperform from Market Perform at CJS Securities
04/02/20 Benchmark
Benchmark starts Quanex at Buy with stock back at 2009 levels
04/02/20 Benchmark
Quanex initiated with a Buy at Benchmark
03/10/20 Sidoti
Quanex upgraded to Buy from Neutral at Sidoti
COO Cooper Companies
$371.84 /

-9.125 (-2.40%)

02/11/21 Piper Sandler
Cooper Companies price target raised to $435 from $370 at Piper Sandler
01/25/21 Wells Fargo
Cooper Companies price target raised to $445 from $415 at Wells Fargo
12/04/20 Citi
Cooper Companies price target raised to $355 from $330 at Citi
12/04/20 KeyBanc
Cooper Companies price target raised to $367 from $349 at KeyBanc
ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

01/29/21 Piper Sandler
Alphatec price target raised to $17 from $12 at Piper Sandler
01/12/21 Piper Sandler
Piper remains buyer of Alphatec despite Covid pressures
12/21/20 H.C. Wainwright
Alphatec price target raised to $16 from $12 at H.C. Wainwright
12/18/20 Lake Street
Alphatec price target raised to $20 from $15 at Lake Street
SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

03/04/21 B. Riley
B. Riley starts American Outdoor Brands with Buy, $32 price target
12/04/20 Lake Street
Lake Street ups Smith & Wesson Brands price target to $28 after earnings
10/05/20 B. Riley
Firearm demand has seen meaningful uptick, says B. Riley Securities
09/24/20
Fly Intel: Top five analyst initiations
IMAX Imax
$20.78 /

-0.98 (-4.50%)

03/01/21 Wedbush
Imax price target raised to $22 from $14 at Wedbush
02/16/21 B. Riley
IMAX format positioned to gain post-pandemic share, says B. Riley Securities
02/16/21 Macquarie
Imax remains best way to play theatrical space, says Macquarie
02/15/21 Benchmark
Benchmark boosts Imax target to $22, says movie goers will return
JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

01/28/21 Piper Sandler
Jamf Holding remains a top idea for 2021 at Piper Sandler
01/05/21 Canaccord
Jamf Holding metrics 'bode well' for strong Q4, says Canaccord
09/02/20 Canaccord
Jamf Holding upside likely in Q3, says Canaccord
08/17/20
Fly Intel: Top five analyst initiations
WTRH Waitr Holdings
$2.99 /

-0.19 (-5.97%)

11/10/20 B. Riley
Waitr Holdings price target lowered to $7 from $8 at B. Riley Securities
07/22/20 B. Riley
B. Riley FBR starts Waitr at Buy, calls attractive takeout candidate
07/22/20 B. Riley
Waitr Holdings initiated with a Buy at B. Riley FBR
07/09/20 Deutsche Bank
Waitr Holdings downgraded to Hold on valuation at Deutsche Bank
OCUL Ocular Therapeutix
$17.29 /

-0.31 (-1.76%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
WDC Western Digital
$63.48 /

-6.3 (-9.03%)

03/04/21 Goldman Sachs
Western Digital upgraded to Buy from Neutral at Goldman Sachs
03/01/21 Barclays
Western Digital price target raised to $75 from $53 at Barclays
02/25/21 Mizuho
Western Digital price target raised to $80 from $65 at Mizuho
02/24/21 Benchmark
Benchmark says Biden order bodes well for Nova Measuring, other semi suppliers
EVFM Evofem
$3.27 /

-0.325 (-9.05%)

10/01/20 Stifel
Evofem initiated with a Buy at Stifel
08/20/20 Morgan Stanley
Evofem initiated with an Equal Weight at Morgan Stanley
08/20/20 Morgan Stanley
Evofem initiated with an Equal Weight at Morgan Stanley
08/10/20 Oppenheimer
Evofem price target raised to $25 from $18 at Oppenheimer
MDLA Medallia
$37.82 /

-2.01 (-5.05%)

03/04/21 Citi
Citi adds Medallia to 'Value Creators' list, removes Dropbox
02/23/21 Citi
Medallia upgraded to Buy from Neutral at Citi
01/19/21 BTIG
Medallia price target raised to $49 from $37 at BTIG
01/19/21 BofA
Medallia initiated with a Buy at BofA
DMTK DermTech
$52.64 /

-11.36 (-17.75%)

02/11/21 Lake Street
DermTech price target raised to $79 from $52 at Lake Street
01/21/21 Oppenheimer
Oppenheimer starts DermTech with Outperform, $53 target
01/21/21 Oppenheimer
DermTech initiated with an Outperform at Oppenheimer
01/20/21 Craig-Hallum
DermTech price target raised to $49 from $23 at Craig-Hallum
OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

03/01/21 Credit Suisse
Opendoor Technologies initiated with an Outperform at Credit Suisse
02/19/21
Fly Intel: Top five analyst initiations
02/19/21 KeyBanc
Opendoor Technologies initiated with an Overweight at KeyBanc
01/06/21 Wedbush
Wedbush bullish on Opendoor Technologies, initiates with an Outperform
SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

12/08/20 Wolfe Research
SmileDirectClub upgraded to Outperform from Peer Perform at Wolfe Research
11/24/20 JPMorgan
JPMorgan reiterates Overweight on SmileDirectClub after management meetings
09/17/20 Stifel
SmileDirectClub price target raised to $14 from $11 at Stifel
09/09/20 Wolfe Research
Wolfe Research upgrades SmileDirectClub to Peer Perform as shifts pay off
GWRE Guidewire
$106.80 /

-2.79 (-2.55%)

01/13/21 Goldman Sachs
Sapiens initiated with a Neutral at Goldman Sachs
10/14/20 DA Davidson
Guidewire model reset is 'right move', says DA Davidson
10/14/20 Needham
Guidewire price target lowered to $130 from $145 at Needham
09/08/20 Barclays
Duck Creek Technologies initiated with an Equal Weight at Barclays
COST Costco
$319.35 /

-4.53 (-1.40%)

02/03/21 Baird
Costco January core comps re-accelerated, says Baird
02/02/21 Cleveland Research
Costco U.S. sales slightly improved in January, says Cleveland Research
01/07/21 Deutsche Bank
Costco price target raised to $347 from $344 at Deutsche Bank
01/06/21 Baird
Costco saw some deceleration in December core comp sales, says Baird
AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

03/02/21 Credit Suisse
Broadcom price target raised to $580 from $480 at Credit Suisse
03/01/21 JPMorgan
Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan
02/26/21 Oppenheimer
Broadcom price target raised to $575 from $500 at Oppenheimer
02/26/21 Oppenheimer
Broadcom price target raised to $575 from $500 at Oppenheimer
WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

12/09/20 Morgan Stanley
Salesforce $50B revenue target unlikely a source of upside, says Morgan Stanley
12/09/20 Canaccord
Salesforce valuation compelling especially on pullback, says Canaccord
12/09/20 Morgan Stanley
Slack Technologies upgraded to Equal Weight from Underweight at Morgan Stanley
12/03/20 Wedbush
Slack Technologies upgraded to Neutral from Underperform at Wedbush
WTRH Waitr Holdings
$2.99 /

-0.19 (-5.97%)

WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

OCUL Ocular Therapeutix
$17.29 /

-0.31 (-1.76%)

NX Quanex
$24.56 /

-0.26 (-1.05%)

MDLA Medallia
$37.82 /

-2.01 (-5.05%)

MANU Manchester United
$18.72 /

-0.84 (-4.29%)

JAMF Jamf Holding
$36.45 /

-1.33 (-3.52%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

GWRE Guidewire
$106.80 /

-2.79 (-2.55%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

EVFM Evofem
$3.27 /

-0.325 (-9.05%)

DMTK DermTech
$52.64 /

-11.36 (-17.75%)

COST Costco
$319.35 /

-4.53 (-1.40%)

COO Cooper Companies
$371.84 /

-9.125 (-2.40%)

AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

  • 05
    Feb
  • 07
    Jan
  • 07
    Jan
  • 16
    Dec
  • 24
    Nov
  • 19
    Nov
  • 19
    Nov
  • 19
    Nov
  • 14
    Oct
  • 14
    Oct
  • 22
    Jul
  • 03
    Jun
  • 20
    May
WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

COST Costco
$319.35 /

-4.53 (-1.40%)

WTRH Waitr Holdings
$2.99 /

-0.19 (-5.97%)

WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

PLYA Playa Hotels & Resorts
$6.90 /

-0.105 (-1.50%)

OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

OCUL Ocular Therapeutix
$17.29 /

-0.31 (-1.76%)

NX Quanex
$24.56 /

-0.26 (-1.05%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

DMTK DermTech
$52.64 /

-11.36 (-17.75%)

COST Costco
$319.35 /

-4.53 (-1.40%)

AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

WORK Slack Technologies
$39.97 /

-0.26 (-0.65%)

WDC Western Digital
$63.48 /

-6.3 (-9.03%)

SWBI Smith & Wesson Brands
$15.79 /

-0.54 (-3.31%)

SDC SmileDirectClub
$10.63 /

-0.28 (-2.57%)

OPEN Opendoor Technologies
$24.40 /

-4.46 (-15.45%)

IMAX Imax
$20.78 /

-0.98 (-4.50%)

GPS Gap
$25.43 /

-0.31 (-1.20%)

EVFM Evofem
$3.27 /

-0.325 (-9.05%)

DMTK DermTech
$52.64 /

-11.36 (-17.75%)

COST Costco
$319.35 /

-4.53 (-1.40%)

AVGO Broadcom
$443.23 /

-19.235 (-4.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.